Colin Love

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Colin Love

Earlier roles on record: COO at Replimune Group, Inc. (REPL) until May 31, 2024. Replimune Group, Inc. reported in an 8-K filed March 26, 2024 that Colin Love retired as chief operating officer, effective May 31, 2024.

“Dr. Colin Love, the Company's current chief operating officer, will retire from the Company, effective May 31, 2024”

Replimune Group, Inc. Form 8-K, filed March 26, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Colin Love's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Replimune Group, Inc. (REPL)
COO

Proxy statement

Start not stated–2024-05-31

Company network

Recorded roles and call appearances connecting this person to public companies.

Replimune Group, Inc.

REPL

COO

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Retired: chief operating officer Replimune Group, Inc. (REPL)
2024-05-31